Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule motor activity	DNHD1 KIF13B KIF1A DYNC2H1 KIF1B KIF15	1.18e-05	70	145	6	GO:0003777
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNHD1 KIF13B MYH10 KIF1A DYNC2H1 KIF1B KIF15	2.48e-05	118	145	7	GO:0003774
GeneOntologyMolecularFunction	cytoskeletal protein binding	KIF13B MYH10 ANK2 KIF1A SPTA1 ATCAY KIF1B NCKIPSD SPAG8 PARVG DCTN1 PTPRC BRCA1 KIF15 BRCA2 BMP10 XIRP2 MICAL3 CEP295 ALDOA ADSS1	4.55e-05	1099	145	21	GO:0008092
GeneOntologyMolecularFunction	plus-end-directed microtubule motor activity	KIF1A KIF1B KIF15	2.37e-04	17	145	3	GO:0008574
GeneOntologyMolecularFunction	pyrophosphatase activity	KIF13B GTPBP4 KIF1A DYNC2H1 KIF1B CHD9 TRIM23 TRAP1 RGS20 GBP4 KIF15 NAV2 CCT6B ENPP5 DDX3Y ADSS1	4.01e-04	839	145	16	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	KIF13B GTPBP4 KIF1A DYNC2H1 KIF1B CHD9 TRIM23 TRAP1 RGS20 GBP4 KIF15 NAV2 CCT6B ENPP5 DDX3Y ADSS1	4.06e-04	840	145	16	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	KIF13B GTPBP4 KIF1A DYNC2H1 KIF1B CHD9 TRIM23 TRAP1 RGS20 GBP4 KIF15 NAV2 CCT6B ENPP5 DDX3Y ADSS1	4.06e-04	840	145	16	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	KIF13B GTPBP4 KIF1A DYNC2H1 KIF1B CHD9 TRIM23 TRAP1 RGS20 GBP4 KIF15 NAV2 CCT6B DDX3Y ADSS1	5.25e-04	775	145	15	GO:0017111
GeneOntologyBiologicalProcess	centrosome cycle	MCPH1 ODF2 DCTN1 BRCA1 KIF15 BRCA2 CEP295 CEP152	2.24e-05	164	146	8	GO:0007098
GeneOntologyBiologicalProcess	positive regulation of protein binding	SPTA1 PLXND1 SPAG8 STK4 LRP1 RAPGEF2	3.13e-05	85	146	6	GO:0032092
GeneOntologyBiologicalProcess	microtubule organizing center organization	MCPH1 ODF2 DCTN1 BRCA1 KIF15 BRCA2 CEP295 CEP152	4.19e-05	179	146	8	GO:0031023
GeneOntologyBiologicalProcess	microtubule-based process	DNHD1 KIF13B MCPH1 KIF1A DYNC2H1 KIF1B ODF2 DCTN1 ENO4 BRCA1 KIF15 BRCA2 TTC21B MAP3K11 KATNIP CEP295 CEP152 ZW10 HYDIN DCTN3	5.77e-05	1058	146	20	GO:0007017
GeneOntologyCellularComponent	microtubule associated complex	DNHD1 KIF13B KIF1A DYNC2H1 KIF1B DCTN1 KIF15 DCTN3	1.97e-05	161	148	8	GO:0005875
GeneOntologyCellularComponent	supramolecular fiber	KIF13B MYH10 ANK2 KIF1A DYNC2H1 KIF1B NCKIPSD ODF2 SPAG8 TEK DCTN1 RYR2 KIF15 BMP10 XIRP2 MAP3K11 AKAP13 CEP295 ZW10 ALDOA DCTN3	8.78e-05	1179	148	21	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KIF13B MYH10 ANK2 KIF1A DYNC2H1 KIF1B NCKIPSD ODF2 SPAG8 TEK DCTN1 RYR2 KIF15 BMP10 XIRP2 MAP3K11 AKAP13 CEP295 ZW10 ALDOA DCTN3	9.65e-05	1187	148	21	GO:0099081
GeneOntologyCellularComponent	microtubule organizing center	RAPGEF6 MCPH1 ODF2 SPAG8 TEK DCTN1 FANCE BRCA1 KIF15 BRCA2 CDC16 LRP1 MAP3K11 CEP295 CEP152 DCTN3 PDZD2	2.81e-04	919	148	17	GO:0005815
GeneOntologyCellularComponent	centrosome	RAPGEF6 MCPH1 ODF2 TEK DCTN1 FANCE BRCA1 KIF15 BRCA2 CDC16 MAP3K11 CEP295 CEP152 DCTN3 PDZD2	3.80e-04	770	148	15	GO:0005813
GeneOntologyCellularComponent	kinesin complex	KIF13B KIF1A KIF1B KIF15	3.99e-04	49	148	4	GO:0005871
GeneOntologyCellularComponent	microtubule	KIF13B KIF1A DYNC2H1 KIF1B ODF2 SPAG8 DCTN1 KIF15 MAP3K11 CEP295 ZW10 DCTN3	4.21e-04	533	148	12	GO:0005874
GeneOntologyCellularComponent	spindle	MYH10 CLTCL1 ODF2 SPAG8 DCTN1 KIF15 CDC16 MICAL3 CEP295 ZW10 DCTN3	5.42e-04	471	148	11	GO:0005819
HumanPheno	Abnormal shape of the palpebral fissure	MKRN3 FANCA FANCE BRCA1 KIF15 BRCA2 EHMT1	1.71e-05	65	66	7	HP:0200005
HumanPheno	Duodenal stenosis	FANCA TTC7A FANCE BRCA1 BRCA2	2.92e-05	29	66	5	HP:0100867
HumanPheno	Small intestinal stenosis	FANCA TTC7A FANCE BRCA1 BRCA2	2.92e-05	29	66	5	HP:0012848
MousePheno	lethality at weaning, incomplete penetrance	DSG3 ZNF423 LPIN1 PTPRC MAP3K11 RORA	2.01e-06	43	124	6	MP:0011084
Domain	Kinesin-like_KIF1-typ	KIF13B KIF1A KIF1B	1.79e-06	4	144	3	IPR022140
Domain	KIF1B	KIF13B KIF1A KIF1B	1.79e-06	4	144	3	PF12423
Domain	Kinesin_assoc	KIF13B KIF1A KIF1B	8.83e-06	6	144	3	PF16183
Domain	Kinesin-like	KIF13B KIF1A KIF1B	8.83e-06	6	144	3	IPR022164
Domain	Kinesin_assoc	KIF13B KIF1A KIF1B	8.83e-06	6	144	3	IPR032405
Domain	DUF3694	KIF13B KIF1A KIF1B	8.83e-06	6	144	3	PF12473
Domain	P-loop_NTPase	DNHD1 KIF13B GTPBP4 MYH10 KIF1A DYNC2H1 KIF1B CHD9 TRIM23 GBP4 KIF15 MTHFD1 ERAL1 NAV2 DDX3Y HS3ST1 HYDIN ADSS1	9.41e-05	848	144	18	IPR027417
Domain	-	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 AKAP13 ANKRD45	1.33e-04	248	144	9	1.25.40.20
Domain	Ankyrin_rpt-contain_dom	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 AKAP13 ANKRD45	1.59e-04	254	144	9	IPR020683
Domain	Ank_2	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	2.67e-04	215	144	8	PF12796
Domain	Kinesin-like_fam	KIF13B KIF1A KIF1B KIF15	3.31e-04	43	144	4	IPR027640
Domain	-	KIF13B KIF1A KIF1B KIF15	3.62e-04	44	144	4	3.40.850.10
Domain	Kinesin	KIF13B KIF1A KIF1B KIF15	3.62e-04	44	144	4	PF00225
Domain	KISc	KIF13B KIF1A KIF1B KIF15	3.62e-04	44	144	4	SM00129
Domain	KINESIN_MOTOR_1	KIF13B KIF1A KIF1B KIF15	3.62e-04	44	144	4	PS00411
Domain	Kinesin_motor_dom	KIF13B KIF1A KIF1B KIF15	3.62e-04	44	144	4	IPR001752
Domain	KINESIN_MOTOR_2	KIF13B KIF1A KIF1B KIF15	3.62e-04	44	144	4	PS50067
Domain	Ank	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	3.96e-04	228	144	8	PF00023
Domain	Glyco_hydro_38_C	MAN2B2 MAN2B1	5.81e-04	5	144	2	IPR011682
Domain	Alpha-mann_mid	MAN2B2 MAN2B1	5.81e-04	5	144	2	PF09261
Domain	Glyco_hydro_57/38_cen	MAN2B2 MAN2B1	5.81e-04	5	144	2	IPR028995
Domain	Glyco_hydro_38	MAN2B2 MAN2B1	5.81e-04	5	144	2	PF01074
Domain	-	MAN2B2 MAN2B1	5.81e-04	5	144	2	1.20.1270.50
Domain	-	MAN2B2 MAN2B1	5.81e-04	5	144	2	3.20.110.10
Domain	Alpha-mann_mid	MAN2B2 MAN2B1	5.81e-04	5	144	2	SM00872
Domain	Glyco_hydro_38_N	MAN2B2 MAN2B1	5.81e-04	5	144	2	IPR000602
Domain	Glyco_hydro_38/57_N	MAN2B2 MAN2B1	5.81e-04	5	144	2	IPR027291
Domain	Glyco_hydro_38_cen	MAN2B2 MAN2B1	5.81e-04	5	144	2	IPR015341
Domain	Glyco_hydro_38C	MAN2B2 MAN2B1	5.81e-04	5	144	2	PF07748
Domain	ANK	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	7.45e-04	251	144	8	SM00248
Domain	ANK_REPEAT	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	7.84e-04	253	144	8	PS50088
Domain	ANK_REP_REGION	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	8.04e-04	254	144	8	PS50297
Domain	Ankyrin_rpt	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	9.83e-04	262	144	8	IPR002110
Domain	-	CLTCL1 SRP72 TTC7A FICD CDC16 TTC21B TTC38	1.13e-03	207	144	7	1.25.40.10
Domain	RNase_Zc3h12a	ZC3H12B ZC3H12C	1.21e-03	7	144	2	PF11977
Domain	Glyco_hydro/deAcase_b/a-brl	MAN2B2 MAN2B1	1.21e-03	7	144	2	IPR011330
Domain	RNase_Zc3h12_NYN	ZC3H12B ZC3H12C	1.21e-03	7	144	2	IPR021869
Domain	FHA	KIF13B KIF1A KIF1B	1.28e-03	28	144	3	SM00240
Domain	FHA_DOMAIN	KIF13B KIF1A KIF1B	1.72e-03	31	144	3	PS50006
Domain	FHA	KIF13B KIF1A KIF1B	1.72e-03	31	144	3	PF00498
Domain	TPR_REGION	SRP72 TTC7A FICD CDC16 TTC21B TTC38	1.77e-03	165	144	6	PS50293
Domain	TPR	SRP72 TTC7A FICD CDC16 TTC21B TTC38	1.77e-03	165	144	6	PS50005
Domain	Plexin_cytopl	PLXNA3 PLXND1	2.05e-03	9	144	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXND1	2.05e-03	9	144	2	IPR013548
Domain	Plexin	PLXNA3 PLXND1	2.05e-03	9	144	2	IPR031148
Domain	TPR-like_helical_dom	CLTCL1 SRP72 TTC7A FICD CDC16 TTC21B TTC38	2.23e-03	233	144	7	IPR011990
Domain	CAP_GLY	KIF13B DCTN1	2.55e-03	10	144	2	PF01302
Domain	CAP_GLY	KIF13B DCTN1	2.55e-03	10	144	2	SM01052
Domain	-	KIF13B DCTN1	2.55e-03	10	144	2	2.30.30.190
Domain	CAP_GLY_1	KIF13B DCTN1	2.55e-03	10	144	2	PS00845
Domain	CAP_GLY_2	KIF13B DCTN1	2.55e-03	10	144	2	PS50245
Domain	CAP-Gly_domain	KIF13B DCTN1	2.55e-03	10	144	2	IPR000938
Domain	-	KIF13B KIF1A KIF1B	2.66e-03	36	144	3	2.60.200.20
Domain	FHA_dom	KIF13B KIF1A KIF1B	2.66e-03	36	144	3	IPR000253
Domain	TPR_repeat	SRP72 TTC7A FICD CDC16 TTC21B	3.71e-03	133	144	5	IPR019734
Domain	Kinesin_motor_CS	KIF13B KIF1A KIF1B	3.86e-03	41	144	3	IPR019821
Domain	Dynein_HC_stalk	DNHD1 DYNC2H1	5.06e-03	14	144	2	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DYNC2H1	5.06e-03	14	144	2	IPR013602
Domain	DHC_N2	DNHD1 DYNC2H1	5.06e-03	14	144	2	PF08393
Domain	-	MAN2B2 MAN2B1	5.06e-03	14	144	2	2.60.40.1180
Domain	MT	DNHD1 DYNC2H1	5.06e-03	14	144	2	PF12777
Domain	DHC_fam	DNHD1 DYNC2H1	5.80e-03	15	144	2	IPR026983
Domain	Dynein_heavy	DNHD1 DYNC2H1	5.80e-03	15	144	2	PF03028
Domain	Glyco_hydro_b	MAN2B2 MAN2B1	5.80e-03	15	144	2	IPR013780
Domain	Dynein_heavy_dom	DNHD1 DYNC2H1	5.80e-03	15	144	2	IPR004273
Domain	TPR-contain_dom	SRP72 TTC7A FICD CDC16 TTC21B	6.16e-03	150	144	5	IPR013026
Domain	Gal_mutarotase_SF_dom	MAN2B2 MAN2B1	7.44e-03	17	144	2	IPR011013
Domain	SMAD_FHA_domain	KIF13B KIF1A KIF1B	7.53e-03	52	144	3	IPR008984
Pathway	REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	KIF13B KIF1A KIF1B DCTN1 KIF15 PLA2G6 ZW10 DCTN3	7.25e-06	131	108	8	MM15497
Pathway	REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	KIF13B KIF1A KIF1B DCTN1 KIF15 PLA2G6 ZW10 DCTN3	8.57e-06	134	108	8	M27751
Pathway	BIOCARTA_ATRBRCA_PATHWAY	FANCA FANCE BRCA1 BRCA2	2.14e-05	22	108	4	M9703
Pathway	BIOCARTA_BARD1_PATHWAY	FANCA FANCE BRCA1	2.38e-05	8	108	3	M22050
Pathway	REACTOME_M_PHASE	MCPH1 ODF2 DCTN1 NCAPG2 NUP205 LPIN1 NDC1 CDC16 CEP152 PSME3 ZW10 DCTN3	4.01e-05	387	108	12	MM15364
Pathway	KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE	DYNC2H1 DCTN1 ZW10 DCTN3	7.66e-05	30	108	4	M47889
Pathway	REACTOME_M_PHASE	MCPH1 ODF2 DCTN1 NCAPG2 NUP205 LPIN1 NDC1 CDC16 CEP152 PSME3 ZW10 DCTN3	8.22e-05	417	108	12	M27662
Pathway	REACTOME_MEMBRANE_TRAFFICKING	KIF13B CLTCL1 ANK2 KIF1A SPTA1 KIF1B DCTN1 F8 TBC1D20 SEC24D TBC1D10B KIF15 PLA2G6 ZW10 DCTN3	8.86e-05	630	108	15	M11480
Pathway	REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC	KIF13B KIF1A KIF1B DCTN1 KIF15 PLA2G6 ZW10 DCTN3	1.01e-04	189	108	8	MM15356
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	KIF13B CLTCL1 ANK2 KIF1A SPTA1 KIF1B DCTN1 F8 TBC1D20 SEC24D TBC1D10B KIF15 LRP1 PLA2G6 ZW10 DCTN3	1.23e-04	725	108	16	M27507
Pathway	REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC	KIF13B KIF1A KIF1B DCTN1 KIF15 PLA2G6 ZW10 DCTN3	1.66e-04	203	108	8	M27654
Pathway	REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	ANK2 SPTA1 DCTN1 F8 TBC1D20 SEC24D DCTN3	1.94e-04	156	108	7	M27097
Pathway	BIOCARTA_ATRBRCA_PATHWAY	FANCA BRCA1 BRCA2	3.88e-04	19	108	3	MM1478
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	KIF13B KIF1A SPTA1 KIF1B DCTN1 F8 TBC1D20 SEC24D TBC1D10B KIF15 LRP1 PLA2G6 ZW10 DCTN3	4.00e-04	645	108	14	MM15232
Pathway	PID_FANCONI_PATHWAY	FANCA FANCE BRCA1 BRCA2	4.51e-04	47	108	4	M1
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	ANK2 SPTA1 DCTN1 F8 TBC1D20 SEC24D DCTN3	5.83e-04	187	108	7	M961
Pathway	REACTOME_CELL_CYCLE	MCPH1 ODF2 DCTN1 NCAPG2 NUP205 LPIN1 NDC1 BRCA1 CDC16 CEP152 PSME3 ZW10 DCTN3	6.95e-04	603	108	13	MM14635
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLXNA3 RAPGEF6 CLTCL1 MAN2B1 PCNX3 INTS1 GRID1 PLXND1 MED13L DCTN1 C2CD2 KIAA2013 FANCA RPAP1 EHMT1 NAV2 MAP3K11 PLA2G6 AKAP13 MICAL3 TTC38	1.05e-08	1105	148	21	35748872
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MYH10 MAN2B2 KIF1A SPTA1 KIF1B NCKIPSD DCTN1 TLR8 TRIM23 TRAP1 BRCA2 MTHFD1 CCT6B DDX3Y ALDOA	7.48e-08	621	148	15	22794259
Pubmed	The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links.	FANCA BRCA1 BRCA2	7.55e-08	3	148	3	32466131
Pubmed	Defining the membrane proteome of NK cells.	GTPBP4 NIBAN1 CLTCL1 INTS1 DCTN1 NCAPG2 KIAA2013 NUP205 TRAP1 NDC1 PTPRC KIF15 MTHFD1 MAP3K11 DDX3Y PLEKHA5 AKAP13 PSME3 ZW10 ALDOA	1.32e-07	1168	148	20	19946888
Pubmed	Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.	MCPH1 FANCA FANCE BRCA1 BRCA2	2.03e-07	31	148	5	19690177
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PLXNA3 KIF13B MYH10 PDE6A CLTCL1 ANK2 PCDHGA4 SPTA1 SRP72 ODF2 DCTN1 RYR2 KIAA2013 NUP205 TRAP1 BRCA1 FAM186A DGKK NAV2 CEP295 PLCH1 TASOR	2.14e-07	1442	148	22	35575683
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	INTS1 NCAPG2 FANCA ERAL1 AKAP13 MICAL3 ARMC6	3.30e-07	104	148	7	31240132
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZNF148 MCPH1 MED9 MED13L NCAPG2 FANCA FANCE BRCA1 BRCA2 PSME3 MRGBP EXOC3L2	6.09e-07	453	148	12	29656893
Pubmed	Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis.	KIF1B DCTN1 DCTN3	7.50e-07	5	148	3	26954557
Pubmed	BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.	FANCA BRCA1 BRCA2	7.50e-07	5	148	3	37549632
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	CAND2 ANK2 PEG10 KIF1B LAMA2 SRP72 DCTN1 SF1 ANKRD46 XIRP2 PSME3 ALDOA	1.60e-06	497	148	12	23414517
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MKRN3 HDAC9 ANK2 KIF1A PEG10 ZNF423 KIF1B CHD9 MED13L ODF2 DCTN1 SF1 LDB2 PNMA2 LRP1 MAP3K11 ENPP5 RAPGEF2 ALDOA	2.46e-06	1285	148	19	35914814
Pubmed	Fanconi Anemia	FANCA FANCE BRCA1 BRCA2	2.62e-06	23	148	4	20301575
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RAPGEF6 KIF1B NCKIPSD PBK PARVG STK4 PNMA2 PLEKHA5 CEP295 CEP152 RAPGEF2	3.61e-06	446	148	11	24255178
Pubmed	Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome.	KIF13B KIF1A KIF1B KIF15	3.72e-06	25	148	4	9275178
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	INTS1 TENM4 RPAP1 RTL9 HACE1 NAV2 MICAL3	4.42e-06	153	148	7	10718198
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RAPGEF6 MAN2B1 SRP72 NCAPG2 FANCA LPIN1 TBC1D10B RPAP1 PLEKHA5 AKAP13 MICAL3 PLCH1 TASOR	4.59e-06	650	148	13	38777146
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GTPBP4 ZNF148 CHD9 TTC7A TBC1D10B BRCA1 CDC16 RTL9 PNMA2 LRP1 EHMT1 CEP295 MRGBP RAPGEF2 UNC80 CDH16 ARMC6	5.89e-06	1116	148	17	31753913
Pubmed	A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.	MYH10 ANK2 KIF1B DCTN1 CEP152	5.90e-06	60	148	5	20682791
Pubmed	Conserved overlapping gene arrangement, restricted expression, and biochemical activities of DNA polymerase ν (POLN).	FANCA BRCA1 BRCA2	6.23e-06	9	148	3	26269593
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KIF1B PLXND1 TRIM23 RYR2 ANKRD46 SEC24D NDC1 BRCA1 MTHFD1 EHMT1 PSME3 RAPGEF2 ALDOA TASOR	6.41e-06	777	148	14	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 KIF13B MAN2B2 DYNC2H1 KIAA2013 TTC21B MICAL3 CEP152 PLCH1 TASOR UNC80	9.29e-06	493	148	11	15368895
Pubmed	Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.	FANCA FANCE BRCA1 BRCA2	1.17e-05	33	148	4	19714462
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	ZNF148 DYNC2H1 SLC26A2 PEG10 ROR1 INTS1 PLXND1 NCAPG2 C2CD2 NUP205 NDC1 MTHFD1 PSME3 ZW10 CDH16 CDH17	1.27e-05	1061	148	16	33845483
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	LAMA2 MED13L TENM4 LRP1 UNC80	1.35e-05	71	148	5	33541421
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KIF13B CAND2 DYNC2H1 KIF1B DCTN1 NCAPG2 NUP205 STK4 TRAP1 CDC16 RTL9 TTC21B PLEKHA5 KATNIP NKTR ZW10 TMEM184B DCTN3	1.40e-05	1321	148	18	27173435
Pubmed	MRG15 is a novel PALB2-interacting factor involved in homologous recombination.	BRCA1 BRCA2 MRGBP	1.62e-05	12	148	3	19553677
Pubmed	Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.	BRCA1 BRCA2	1.80e-05	2	148	2	29480828
Pubmed	A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.	BRCA1 BRCA2	1.80e-05	2	148	2	17924331
Pubmed	Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.	BRCA1 BRCA2	1.80e-05	2	148	2	12833555
Pubmed	Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.	BRCA1 BRCA2	1.80e-05	2	148	2	14735173
Pubmed	Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.80e-05	2	148	2	16032702
Pubmed	Oral contraceptive use and BRCA penetrance: a case-only study.	BRCA1 BRCA2	1.80e-05	2	148	2	19549808
Pubmed	Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.	BRCA1 BRCA2	1.80e-05	2	148	2	34101484
Pubmed	Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.	BRCA1 BRCA2	1.80e-05	2	148	2	26961146
Pubmed	Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study.	BRCA1 BRCA2	1.80e-05	2	148	2	20512419
Pubmed	Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.	BRCA1 BRCA2	1.80e-05	2	148	2	37804357
Pubmed	Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.	BRCA1 BRCA2	1.80e-05	2	148	2	22053997
Pubmed	BRCA mutations in women with inflammatory breast cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	29044548
Pubmed	Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.	BRCA1 BRCA2	1.80e-05	2	148	2	33834176
Pubmed	Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.	BRCA1 BRCA2	1.80e-05	2	148	2	18200524
Pubmed	Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.	BRCA1 BRCA2	1.80e-05	2	148	2	29298688
Pubmed	Fertility in women with BRCA mutations: a case-control study.	BRCA1 BRCA2	1.80e-05	2	148	2	19200971
Pubmed	Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.	BRCA1 BRCA2	1.80e-05	2	148	2	16030099
Pubmed	Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.	BRCA1 BRCA2	1.80e-05	2	148	2	28212807
Pubmed	Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	11448436
Pubmed	Rapid evolution of BRCA1 and BRCA2 in humans and other primates.	BRCA1 BRCA2	1.80e-05	2	148	2	25011685
Pubmed	Breast magnetic resonance imaging for screening high-risk women.	BRCA1 BRCA2	1.80e-05	2	148	2	23928241
Pubmed	Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	35980168
Pubmed	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.	BRCA1 BRCA2	1.80e-05	2	148	2	11377596
Pubmed	BRCA mutations and risk of prostate cancer in Ashkenazi Jews.	BRCA1 BRCA2	1.80e-05	2	148	2	15131025
Pubmed	Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.	BRCA1 BRCA2	1.80e-05	2	148	2	20033483
Pubmed	Health survey and assessment of the polymorphisms BRCA1/P871L, BRCA1/Q356R, and BRCA2/N372H in female gas station workers in Rio de Janeiro.	BRCA1 BRCA2	1.80e-05	2	148	2	28862356
Pubmed	BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.	BRCA1 BRCA2	1.80e-05	2	148	2	22425665
Pubmed	BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.	BRCA1 BRCA2	1.80e-05	2	148	2	18752448
Pubmed	Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.	BRCA1 BRCA2	1.80e-05	2	148	2	22425664
Pubmed	Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.	BRCA1 BRCA2	1.80e-05	2	148	2	22970155
Pubmed	Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.	BRCA1 BRCA2	1.80e-05	2	148	2	34304065
Pubmed	Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India.	BRCA1 BRCA2	1.80e-05	2	148	2	26625823
Pubmed	Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	26852015
Pubmed	Meta-analysis of BRCA1 and BRCA2 penetrance.	BRCA1 BRCA2	1.80e-05	2	148	2	17416853
Pubmed	Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.	BRCA1 BRCA2	1.80e-05	2	148	2	18175183
Pubmed	Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients.	BRCA1 BRCA2	1.80e-05	2	148	2	38057686
Pubmed	Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.	BRCA1 BRCA2	1.80e-05	2	148	2	27914478
Pubmed	BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.	BRCA1 BRCA2	1.80e-05	2	148	2	16455195
Pubmed	The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.	BRCA1 BRCA2	1.80e-05	2	148	2	23810788
Pubmed	Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.	BRCA1 BRCA2	1.80e-05	2	148	2	29727326
Pubmed	Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.	BRCA1 BRCA2	1.80e-05	2	148	2	35871032
Pubmed	Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.	BRCA1 BRCA2	1.80e-05	2	148	2	22739995
Pubmed	The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.	BRCA1 BRCA2	1.80e-05	2	148	2	27794048
Pubmed	Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.	BRCA1 BRCA2	1.80e-05	2	148	2	20972632
Pubmed	BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.	BRCA1 BRCA2	1.80e-05	2	148	2	19499246
Pubmed	Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.	BRCA1 BRCA2	1.80e-05	2	148	2	19656164
Pubmed	Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.	BRCA1 BRCA2	1.80e-05	2	148	2	15986445
Pubmed	Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	18165636
Pubmed	Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.	BRCA1 BRCA2	1.80e-05	2	148	2	23615136
Pubmed	Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.	BRCA1 BRCA2	1.80e-05	2	148	2	29982601
Pubmed	Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.80e-05	2	148	2	28343309
Pubmed	BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.	BRCA1 BRCA2	1.80e-05	2	148	2	17925560
Pubmed	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	27601588
Pubmed	Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.80e-05	2	148	2	23918944
Pubmed	Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.	BRCA1 BRCA2	1.80e-05	2	148	2	33558422
Pubmed	Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.	BRCA1 BRCA2	1.80e-05	2	148	2	30430339
Pubmed	Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.	BRCA1 BRCA2	1.80e-05	2	148	2	33534430
Pubmed	BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?	BRCA1 BRCA2	1.80e-05	2	148	2	34137566
Pubmed	BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.	BRCA1 BRCA2	1.80e-05	2	148	2	33918338
Pubmed	Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.	BRCA1 BRCA2	1.80e-05	2	148	2	26181175
Pubmed	Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.	BRCA1 BRCA2	1.80e-05	2	148	2	14517958
Pubmed	Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.	BRCA1 BRCA2	1.80e-05	2	148	2	18559571
Pubmed	BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.	BRCA1 BRCA2	1.80e-05	2	148	2	27225819
Pubmed	BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.	BRCA1 BRCA2	1.80e-05	2	148	2	18559594
Pubmed	Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.	BRCA1 BRCA2	1.80e-05	2	148	2	31131559
Pubmed	The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.	BRCA1 BRCA2	1.80e-05	2	148	2	11981002
Pubmed	Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.	BRCA1 BRCA2	1.80e-05	2	148	2	29020660
Pubmed	An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.	BRCA1 BRCA2	1.80e-05	2	148	2	21934105
Pubmed	Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.	BRCA1 BRCA2	1.80e-05	2	148	2	28199346
Pubmed	Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.	BRCA1 BRCA2	1.80e-05	2	148	2	18092194
Pubmed	Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.	BRCA1 BRCA2	1.80e-05	2	148	2	16541324
Pubmed	Investigating the relationship between BRCA1 and BRCA2 genes methylation profile and sperm DNA fragmentation in infertile men.	BRCA1 BRCA2	1.80e-05	2	148	2	31095775
Pubmed	Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.	BRCA1 BRCA2	1.80e-05	2	148	2	36385461
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	FANCA FANCE BRCA1 BRCA2	3.25e-06	20	95	4	548
GeneFamily	7D cadherins	CDH16 CDH17	2.73e-05	2	95	2	1187
GeneFamily	Ankyrin repeat domain containing	ANKRD31 TRPA1 ANK2 ANKRD46 HACE1 EHMT1 PLA2G6 ANKRD45	4.09e-05	242	95	8	403
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B KIF1A KIF1B KIF15	9.86e-05	46	95	4	622
GeneFamily	Mannosidases alpha class 2	MAN2B2 MAN2B1	2.70e-04	5	95	2	1194
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SRP72 TTC7A CDC16 TTC21B TTC38	3.50e-04	115	95	5	769
GeneFamily	Dynactin	DCTN1 DCTN3	4.04e-04	6	95	2	943
GeneFamily	Plexins	PLXNA3 PLXND1	9.60e-04	9	95	2	683
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	MTHFD1 DDX3Y AKAP13	2.44e-03	51	95	3	870
Coexpression	GSE22045_TREG_VS_TCONV_UP	PBK NCAPG2 TTC7A KIF15 FAM186A NAV2 RORA ZW10 TTC38	1.35e-06	189	148	9	M4400
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B NIBAN1 ASPN CYGB LAMA2 CHD9 LRP1 DDX3Y PLEKHA5 RORA NKTR	5.82e-11	195	148	11	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA SPTA1 GRID1 RYR2 TENM4 XIRP2 DGKK PLCH1 HYDIN UNC80	6.40e-10	184	148	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA SPTA1 GRID1 RYR2 TENM4 XIRP2 DGKK PLCH1 HYDIN UNC80	6.40e-10	184	148	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA SPTA1 GRID1 RYR2 TENM4 XIRP2 DGKK PLCH1 HYDIN UNC80	6.40e-10	184	148	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	HDAC9 ANK2 ROR1 LAMA2 RYR2 XIRP2 PLEKHA5 AKAP13 PDZD2	1.18e-08	184	148	9	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	PBK NCAPG2 FANCA NDC1 BRCA1 KIF15 BRCA2 MICAL3 CEP152	1.24e-08	185	148	9	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 ROR1 LAMA2 RYR2 XIRP2 PLEKHA5 AKAP13 MICAL3 PDZD2	1.49e-08	189	148	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA NDC1 BRCA1 KIF15 BRCA2 NAV2 CEP152	1.56e-08	190	148	9	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	NIBAN1 ANK2 ROR1 LAMA2 RYR2 PLEKHA5 AKAP13 MICAL3 PDZD2	1.56e-08	190	148	9	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PBK NCAPG2 FANCA NDC1 BRCA1 KIF15 BRCA2 CEP295 CEP152	1.79e-08	193	148	9	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	MCPH1 PBK NCAPG2 NUP205 FANCA BRCA1 MTHFD1 NAV2 ZW10	1.79e-08	193	148	9	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA NDC1 BRCA1 KIF15 BRCA2 NAV2 CEP152	1.87e-08	194	148	9	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	NIBAN1 ANK2 ROR1 LAMA2 RYR2 XIRP2 PLEKHA5 AKAP13 MICAL3	1.96e-08	195	148	9	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	KIF13B MYH10 ASPN ROR1 LAMA2 RYR2 TENM4 PLEKHA5 RORA	2.14e-08	197	148	9	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DDIT4 LRRC32 PLXND1 TEK F8 LDB2 GBP4 EXOC3L2	1.32e-07	175	148	8	90302e8a44858ef3b2a165b88284d4788d591a99
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 NIBAN1 ANK2 ATCAY ROR1 LAMA2 RYR2 XIRP2	1.38e-07	176	148	8	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLXNA3 NIBAN1 MAN2B2 ASPN PEG10 ZNF423 C2CD2 XIRP2	1.44e-07	177	148	8	30f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF13B NIBAN1 ASPN ROR1 C2CD2 BRCA1 ERAL1 CEP152	1.57e-07	179	148	8	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PBK TEK NCAPG2 LDB2 FANCA BRCA1 KIF15 BRCA2	2.48e-07	190	148	8	31de1727822e9818652946dfb962daee77ffad68
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP295 CEP152	2.48e-07	190	148	8	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	NIBAN1 ANK2 ROR1 LAMA2 RYR2 XIRP2 AKAP13 MICAL3	2.48e-07	190	148	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	HDAC9 ANK2 ROR1 LAMA2 RYR2 PLEKHA5 AKAP13 PDZD2	2.48e-07	190	148	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	NIBAN1 ANK2 ROR1 LAMA2 RYR2 PLEKHA5 AKAP13 PDZD2	2.58e-07	191	148	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTA1 PBK NCAPG2 FANCA PTPRC KIF15 BRCA2 CEP152	2.58e-07	191	148	8	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B CYGB LAMA2 CHD9 DDX3Y PLEKHA5 RORA NKTR	2.58e-07	191	148	8	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 DDIT4 ZNF423 LRRC32 PLXND1 TEK LDB2 CC2D2B	2.91e-07	194	148	8	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	NIBAN1 SPTA1 PBK NCAPG2 FANCA PTPRC KIF15 BRCA2	3.02e-07	195	148	8	7e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 MTHFD1 CEP152	3.02e-07	195	148	8	b65463a804fed2d9a3be9e528ca8b9c98469bc86
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 MTHFD1 CEP152	3.02e-07	195	148	8	cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	SPTA1 PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	3.02e-07	195	148	8	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 MTHFD1 CEP152	3.02e-07	195	148	8	56d8734d020b3da08a5aa9e67999706a9e023a99
ToppCell	Kidney-Endothelial\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	LRRC32 PLXND1 TEK F8 LDB2 GBP4 MAP3K11 EXOC3L2	3.53e-07	199	148	8	b543f0686522df43737e9ffa5c9733e42b8a9f4d
ToppCell	droplet-Fat-SCAT-30m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NIBAN1 PBK TLR8 TTC7A TENM4 PTPRC MRGBP	8.20e-07	153	148	7	2731c3d4ac40ecc22108f8f3f45a069077159125
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	1.42e-06	166	148	7	2642544070564debe2deb2938d2c33997bf5ef02
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF1A PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2	1.47e-06	167	148	7	50c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PBK TEK NCAPG2 FANCA KIF15 BRCA2 NAV2	1.47e-06	167	148	7	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF1A PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2	1.53e-06	168	148	7	d35944fd9fea9934ce1e76b2b35d48e2300cca61
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP295	1.60e-06	169	148	7	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ASPN PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2	1.60e-06	169	148	7	e7514956b2e4298222ec443f98b2f5289451786e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PBK LAMA2 NCAPG2 FANCA FANCE KIF15 BRCA2	1.73e-06	171	148	7	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PBK LAMA2 NCAPG2 FANCA FANCE KIF15 BRCA2	1.73e-06	171	148	7	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 KLK13	2.34e-06	179	148	7	80112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 KLK13	2.43e-06	180	148	7	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 NIBAN1 ANK2 ROR1 LAMA2 RYR2 XIRP2	2.52e-06	181	148	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATG9B LRRC32 PLXND1 TEK RYR2 LDB2 EXOC3L2	2.71e-06	183	148	7	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATG9B LRRC32 PLXND1 TEK RYR2 LDB2 EXOC3L2	2.71e-06	183	148	7	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF423 LRRC32 TEK F8 LDB2 GBP4 EXOC3L2	2.71e-06	183	148	7	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 NIBAN1 ANK2 ROR1 LAMA2 RYR2 XIRP2	2.91e-06	185	148	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	HDAC9 ANK2 ROR1 RYR2 XIRP2 PLEKHA5 PDZD2	2.91e-06	185	148	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANK2 KIF1A ASPN RYR2 TENM4 NAV2 UNC80	2.91e-06	185	148	7	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	2.91e-06	185	148	7	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	3.12e-06	187	148	7	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	3.12e-06	187	148	7	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PBK NCAPG2 BRCA1 KIF15 BRCA2 NAV2 CEP152	3.35e-06	189	148	7	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	NIBAN1 ANK2 ROR1 RYR2 XIRP2 AKAP13 MICAL3	3.35e-06	189	148	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH10 SPTA1 MFSD2B NCAPG2 BRCA1 KIF15 BRCA2	3.35e-06	189	148	7	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 CYGB LAMA2 RYR2 XIRP2 LRP1 PLEKHA5	3.47e-06	190	148	7	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 NIBAN1 ANK2 LAMA2 RYR2 XIRP2 PDZD2	3.47e-06	190	148	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B ASPN CYGB LAMA2 CHD9 LRP1 PLEKHA5	3.72e-06	192	148	7	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK F8 LDB2 EXOC3L2	3.72e-06	192	148	7	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 LRRC32 PLXND1 TEK LDB2 GBP4 EXOC3L2	3.72e-06	192	148	7	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	DYNC2H1 LAMA2 LDB2 SEC24D TENM4 LRP1 RORA	3.72e-06	192	148	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATCAY LRRC32 PLXND1 TEK GBP4 EXOC3L2 HS3ST1	3.85e-06	193	148	7	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 NAV2	3.85e-06	193	148	7	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK F8 LDB2 EXOC3L2	3.85e-06	193	148	7	52e918884877b6659cdca0496390e440f73694a9
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 TEK LDB2 TBC1D20 STK4 MAP3K11 ZC3H12C	3.85e-06	193	148	7	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SLC26A2 PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2	3.85e-06	193	148	7	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 TEK LDB2 TBC1D20 STK4 MAP3K11 ZC3H12C	3.85e-06	193	148	7	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	3.98e-06	194	148	7	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK F8 LDB2 EXOC3L2	3.98e-06	194	148	7	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK F8 LDB2 EXOC3L2	3.98e-06	194	148	7	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK F8 LDB2 EXOC3L2	3.98e-06	194	148	7	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	3'_v3-blood-Lymphocytic_NK-Cycling_NK\|blood / Manually curated celltypes from each tissue	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	3.98e-06	194	148	7	bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.12e-06	195	148	7	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.12e-06	195	148	7	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A DYNC2H1 KIF1B NAV2 DDX3Y NKTR UNC80	4.12e-06	195	148	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A DYNC2H1 KIF1B NAV2 DDX3Y NKTR UNC80	4.12e-06	195	148	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF423 LRRC32 PLXND1 TEK LDB2 GBP4 EXOC3L2	4.26e-06	196	148	7	ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK F8 LDB2 EXOC3L2	4.26e-06	196	148	7	023312af38f816a44b407e0daa32590d953caf99
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PLXND1 TEK F8 LDB2 GBP4 EXOC3L2	4.26e-06	196	148	7	65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NCAPG2 FANCA BRCA1 KIF15 BRCA2 MTHFD1 CEP152	4.26e-06	196	148	7	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.26e-06	196	148	7	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.26e-06	196	148	7	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	MYH10 ANK2 ASPN ROR1 LAMA2 RYR2 RORA	4.26e-06	196	148	7	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASPN ROR1 CYGB LAMA2 SEC24D LRP1 DDX3Y	4.26e-06	196	148	7	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK LDB2 GBP4 EXOC3L2	4.26e-06	196	148	7	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.26e-06	196	148	7	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	PND28-Mesenchymal\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 ASPN CYGB LAMA2 LRP1 DMPK PDZD2	4.26e-06	196	148	7	119265efd2219f328d8152dbee52af8327aec89c
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASPN ROR1 CYGB LAMA2 SEC24D LRP1 DDX3Y	4.26e-06	196	148	7	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	P07-Mesenchymal-myocytic_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NIBAN1 MYH10 ANK2 ASPN CYGB TENM4 RORA	4.40e-06	197	148	7	378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.40e-06	197	148	7	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK LDB2 GBP4 EXOC3L2	4.40e-06	197	148	7	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 CEP152	4.40e-06	197	148	7	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NIBAN1 MYH10 ANK2 ASPN CYGB TENM4 RORA	4.40e-06	197	148	7	b1135378d768fbbe62a75747d1e8653d35252187
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK LDB2 GBP4 EXOC3L2	4.55e-06	198	148	7	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 LRRC32 PLXND1 TEK LDB2 GBP4 EXOC3L2	4.55e-06	198	148	7	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	PBK NCAPG2 FANCA BRCA1 KIF15 BRCA2 MTHFD1	4.55e-06	198	148	7	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PLXND1 TEK F8 LDB2 GBP4 EXOC3L2	4.55e-06	198	148	7	259fbcc0f2ac281a3e4d693de45b986fe5e24841
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 PLXND1 TEK F8 LDB2 GBP4 EXOC3L2	4.55e-06	198	148	7	1378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DSG3 ASPN PBK NCAPG2 FANCA KIF15 BRCA2	4.55e-06	198	148	7	f088badb90c6c2d916195f5649eda102119c9ac6
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A	ZNF787 KIF13B KIF1A TRIM23 FANCE SEC24D RPAP1 CCT6B RAPGEF2 ARMC6	7.43e-07	199	148	10	1703_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	ROR1 CHD9 MED13L TENM4 KIF15 NAV2 PLEKHA5 AKAP13 RAPGEF2	1.85e-06	171	148	9	7535_DN
Drug	AC1L1GT5	KIF13B MAN2B2 MAN2B1 KIF1A KIF1B DCTN1 MAP3K11	2.91e-06	95	148	7	CID000003829
Drug	Trenimon	MCPH1 FANCA FANCE BRCA1	6.16e-06	19	148	4	CID000006235
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A	GTPBP4 PLXND1 SF1 FANCA RPAP1 CCT6B PLEKHA5 AKAP13 TTC38	6.39e-06	199	148	9	1319_DN
Drug	papaverine	PDE6A TRPA1 PLCXD2 PEG10 CYGB ODF2 RYR2 PLCH1	2.04e-05	176	148	8	CID000004680
Drug	Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; HL60; HT_HG-U133A	PLXNA3 KIF13B DDIT4 MCPH1 SPAG8 F8 TLR8 PLCH1	3.40e-05	189	148	8	2405_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A	KIF13B DDIT4 MED9 KIF1B BRCA1 PLA2G6 NKTR ZW10	3.67e-05	191	148	8	2368_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	MYH10 SF1 STK4 PLA2G6 AKAP13 CEP152 NKTR RAPGEF2	4.10e-05	194	148	8	4312_DN
Drug	4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline	FANCA FANCE BRCA1 BRCA2	4.12e-05	30	148	4	ctd:C471109
Drug	ethyl centralite	PLXNA3 PNMA2	4.20e-05	2	148	2	CID000006828
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A	SPAG8 F8 RYR2 SEC24D RPAP1 EHMT1 AKAP13 MICAL3	4.57e-05	197	148	8	3211_DN
Drug	1,1-dimethylbiguanide hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A	ANK2 INTS1 SRP72 MED13L FANCA BRCA1 RAPGEF2 DMPK	4.57e-05	197	148	8	3_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A	HDAC9 MED13L NCAPG2 SF1 SEC24D RPAP1 BRCA1 ZW10	4.57e-05	197	148	8	1386_DN
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A	PLXNA3 PLXND1 RYR2 SEC24D RPAP1 PLA2G6 PLCH1 TTC38	4.73e-05	198	148	8	3537_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A	KIF1A INTS1 RYR2 STK4 LPIN1 PLA2G6 MICAL3 PLCH1	4.73e-05	198	148	8	5289_UP
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A	NIBAN1 ODF2 RYR2 SEC24D BRCA2 CEP152 PSME3 HS3ST1	4.73e-05	198	148	8	5885_DN
Drug	5186223; Up 200; 12uM; MCF7; HT_HG-U133A_EA	MCPH1 SLC26A2 ZNF423 CHD9 FANCA CCT6B AKAP13 ZW10	5.08e-05	200	148	8	885_UP
Disease	synucleinopathy (biomarker_via_orthology)	KIF1A KIF1B DCTN1	4.73e-07	4	146	3	DOID:0050890 (biomarker_via_orthology)
Disease	Bone marrow hypocellularity	FANCA FANCE BRCA2 EXOC3L2	1.67e-06	18	146	4	C1855710
Disease	Fanconi Anemia	FANCA FANCE BRCA1 BRCA2	6.71e-06	25	146	4	C0015625
Disease	Pancytopenia	FANCA FANCE BRCA2 EXOC3L2	7.90e-06	26	146	4	C0030312
Disease	Miller Dieker syndrome	FANCA FANCE BRCA1 BRCA2	1.24e-05	29	146	4	C0265219
Disease	Fanconi anemia (is_implicated_in)	FANCA BRCA1 BRCA2	1.39e-05	10	146	3	DOID:13636 (is_implicated_in)
Disease	ductal carcinoma in situ (biomarker_via_orthology)	BRCA1 BRCA2	2.43e-05	2	146	2	DOID:0060074 (biomarker_via_orthology)
Disease	Hereditary site-specific ovarian cancer syndrome	BRCA1 BRCA2	2.43e-05	2	146	2	C4749652
Disease	Fanconi anemia	FANCA FANCE BRCA2	4.15e-05	14	146	3	cv:C0015625
Disease	mean platelet volume	HDAC9 NIBAN1 PCNX3 PCDHGA4 SPTA1 KIF1B CHD9 PLXND1 ANKRD46 FANCA BCLAF3 STK4 PTPRC MAP3K11 EXOC3L2 TASOR	4.80e-05	1020	146	16	EFO_0004584
Disease	level of tyrosine-protein kinase transmembrane receptor ROR1 in blood serum	ROR1 RORA	7.27e-05	3	146	2	OBA_2043309
Disease	tyrosine-protein kinase transmembrane receptor ROR1 measurement	ROR1 RORA	7.27e-05	3	146	2	EFO_0020831
Disease	Adenocarcinoma of prostate	FANCA BRCA1 BRCA2	1.27e-04	20	146	3	C0007112
Disease	Hereditary breast ovarian cancer syndrome	BRCA1 BRCA2	1.45e-04	4	146	2	cv:C0677776
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	1.45e-04	4	146	2	cv:C0265275
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA1 BRCA2	2.41e-04	5	146	2	DOID:5683 (is_implicated_in)
Disease	neuroimaging measurement	HDAC9 MYH10 MCPH1 ROR1 KIF1B LAMA2 MFSD2B PLXND1 ENO4 BRCA1 NAV2 MAP3K11 RORA RAPGEF2 PLCH1	2.80e-04	1069	146	15	EFO_0004346
Disease	Acute monocytic leukemia	FANCA FANCE BRCA1	2.84e-04	26	146	3	C0023465
Disease	MYELODYSPLASTIC SYNDROME	FANCA FANCE BRCA1 BRCA2	3.46e-04	67	146	4	C3463824
Disease	Adult only	BRCA1 BRCA2	3.60e-04	6	146	2	C3842001
Disease	Nonorganic psychosis	TENM4 PTPRC PLA2G6 CDH17	3.87e-04	69	146	4	C0349204
Disease	Breast Cancer, Familial	MCPH1 BRCA1 BRCA2	4.37e-04	30	146	3	C0346153
Disease	Abnormality of radial ray	FANCA FANCE BRCA2	5.81e-04	33	146	3	C4228778
Disease	interleukin 10 measurement	RAPGEF6 DYNC2H1 ROR1 RORA	6.18e-04	78	146	4	EFO_0004750
Disease	Bipolar Disorder	ROR1 GRID1 STK4 TENM4 BRCA2 MTHFD1 PLA2G6 RORA CDH17	6.41e-04	477	146	9	C0005586
Disease	beta-secretase 1 measurement	RGS20 RORA	6.68e-04	8	146	2	EFO_0009179
Disease	NEPHRONOPHTHISIS 2	ZNF423 TTC21B	6.68e-04	8	146	2	C1865872
Disease	Aqueductal Stenosis	MYH10 HYDIN	6.68e-04	8	146	2	C2936786
Disease	Hydrocephalus	EXOC3L2 HYDIN	8.56e-04	9	146	2	C0020255
Disease	Pancreatic carcinoma, familial	BRCA1 BRCA2	8.56e-04	9	146	2	C2931038
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	ANK2 RYR2	1.07e-03	10	146	2	C1631597
Disease	monocyte percentage of leukocytes	KIF1B MFSD2B CHD9 MED13L FANCA TRAP1 PTPRC BRCA1 CDC16 AKAP13 EXOC3L2	1.07e-03	731	146	11	EFO_0007989
Disease	primary immunodeficiency disease (is_implicated_in)	TLR8 STK4 PTPRC	1.18e-03	42	146	3	DOID:612 (is_implicated_in)
Disease	response to methotrexate, serum alanine aminotransferase measurement	ROR1 RORA PDZD2	1.27e-03	43	146	3	EFO_0004735, GO_0031427
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	1.30e-03	11	146	2	C0265275
Disease	kidney cancer	MCPH1 RORA	1.30e-03	11	146	2	MONDO_0002367
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FANCA BRCA1 BRCA2	1.45e-03	45	146	3	DOID:3748 (is_implicated_in)
Disease	nervous system disease (implicated_via_orthology)	KIF1A KIF1B	1.55e-03	12	146	2	DOID:863 (implicated_via_orthology)
Disease	Mouth Diseases	DDIT4 BRCA1	1.55e-03	12	146	2	C0026636
Disease	Psychotic Disorders	TENM4 PTPRC PLA2G6 CDH17	1.62e-03	101	146	4	C0033975
Disease	matrix metalloproteinase measurement	DYNC2H1 PLA2G6	1.83e-03	13	146	2	EFO_0004744
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 TTC21B	1.83e-03	13	146	2	C0036996
Disease	Benign tumor of pancreas	BRCA1 BRCA2	1.83e-03	13	146	2	C0347284
Disease	FVC change measurement, response to placebo	KIF1A KATNIP	1.83e-03	13	146	2	EFO_0008344, EFO_0010339
Disease	skin melanoma (is_implicated_in)	FANCA BRCA2	2.13e-03	14	146	2	DOID:8923 (is_implicated_in)
Disease	colonic neoplasm, overall survival	DSG3 PARVG	2.13e-03	14	146	2	EFO_0000638, EFO_0004288
Disease	Saldino-Noonan Syndrome	DYNC2H1 TTC21B	2.13e-03	14	146	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 TTC21B	2.13e-03	14	146	2	C0024507
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA1 BRCA2	2.13e-03	14	146	2	C0677776
Disease	mean reticulocyte volume	HDAC9 SPTA1 SF1 LDB2 NUP205 ANKRD46 TTC7A PTPRC ENPP5 AKAP13 EXOC3L2	2.15e-03	799	146	11	EFO_0010701
Disease	Autosomal recessive primary microcephaly	MCPH1 CEP152	2.45e-03	15	146	2	cv:C3711387
Disease	Ischemic stroke, fibrinogen measurement	HDAC9 RAPGEF6 CHD9	2.58e-03	55	146	3	EFO_0004623, HP_0002140
Disease	leukemia	DDIT4 FANCA FANCE	2.58e-03	55	146	3	C0023418
Disease	ovarian cancer (is_implicated_in)	FANCA BRCA1 BRCA2	2.72e-03	56	146	3	DOID:2394 (is_implicated_in)
Disease	adult onset asthma	HDAC9 PTPRC LRP1 RORA	2.85e-03	118	146	4	EFO_1002011
Disease	retinopathy	HDAC9 TENM4	3.15e-03	17	146	2	EFO_0003839
Disease	Herpes Zoster	LRRC32 HACE1	3.15e-03	17	146	2	EFO_0006510
Disease	cortical thickness	HDAC9 MCPH1 ZNF423 ROR1 LAMA2 PLXND1 ENO4 LRP1 NAV2 RORA MICAL3 PLCH1 PDZD2	3.63e-03	1113	146	13	EFO_0004840
Disease	Pancreatic carcinoma	BRCA1 BRCA2	3.93e-03	19	146	2	C0235974
Disease	Cannabis use, age at onset	ZNF423 RYR2	3.93e-03	19	146	2	EFO_0004847, EFO_0007585
Disease	facial asymmetry measurement	ROR1 RORA	3.93e-03	19	146	2	EFO_0009751
Disease	asthma	HDAC9 RAPGEF6 LRRC32 GRID1 ANKRD46 TRAP1 PTPRC LRP1 RORA TASOR	4.29e-03	751	146	10	MONDO_0004979
Disease	sclerosing cholangitis	HDAC9 STK4 TRAP1	4.32e-03	66	146	3	EFO_0004268
Disease	exercise test	RYR2 ZC3H12C	4.36e-03	20	146	2	EFO_0004328
Disease	response to ziprasidone	TENM4 HS3ST1	4.36e-03	20	146	2	GO_0097337
Disease	BREAST CANCER	BRCA1 BRCA2	4.80e-03	21	146	2	114480
Disease	platelet measurement	ZNF787 HDAC9 KIF1B CHD9 EXOC3L2 TASOR	4.92e-03	315	146	6	EFO_0005036

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELNLAMANHDIPPDA	TDRD5	441	Q8NAT2
LAHEPVNELSALMED	TTC21B	816	Q7Z4L5
MEELENSLQRHLPQS	C2orf16	831	Q68DN1
HLAEVMQLEDTPSIQ	EXOC3L2	286	Q2M3D2
QQLLTDLPHDMLDDD	CEP152	31	O94986
AEQPEDCTMQLADHI	DCTN1	736	Q14203
HSHNDVPEENLMLEQ	CCDC7	671	Q96M83
EHTPSALAIMENANV	ALDOA	156	P04075
ADGSQEPTHDILQML	ARMC6	81	Q6NXE6
EPTHDILQMLSDLQE	ARMC6	86	Q6NXE6
LDHPLEDRNTIEMQA	GTPBP4	226	Q9BZE4
ALLGLEEDVMPHQNS	AKAP13	621	Q12802
PHHEQAMQLLLEEDI	ANKRD45	61	Q5TZF3
QEMDNLVAEHPGLVS	CPA2	131	P48052
QVSLLAVDEMHQDLP	BEST1	316	O76090
AELNHMAEVLVPATL	DNHD1	2176	Q96M86
ESAMESHSLLNPNLQ	ANKRD46	156	Q86W74
LDNFLLQQMPLHDTE	CC2D2B	741	Q6DHV5
ALHVLEMSANPLDNN	ASPN	196	Q9BXN1
NSPAEMLHNVTLALE	PARVG	266	Q9HBI0
QSTEERDDMIHQLPL	NUP205	286	Q92621
HDHDIMLLELQSPVQ	KLK13	121	Q9UKR3
LLNVPMEDVNLSSGH	MORC1	776	Q86VD1
EIVQLLLQHMAHPDA	ANK2	511	Q01484
LISDQEFLPCHIMDQ	ANKRD31	1846	Q8N7Z5
ETHISLQVMDINDNP	PCDHGA4	466	Q9Y5G9
DLHPLLQNMAEEIID	OTOA	31	Q7RTW8
VMILNATDADEPNHL	DSG3	176	P32926
DDLLLPADEVNMPHQ	DGKK	386	Q5KSL6
QVMHAADPLEIQADV	MICAL3	1026	Q7RTP6
LINEEHIHMAQSSPA	MED13L	191	Q71F56
IDESLFPAANMNEHL	MCPH1	86	Q8NEM0
RQLEHVMDSAAEDPQ	KIF15	1126	Q9NS87
TALALQQAIHMETDP	INTS1	1046	Q8N201
VHEEPSLIQQLENLM	KATNIP	726	O60303
TPHLVNLNEDPLMSE	KIF1B	531	O60333
ENLMNPRALDFHAET	LRP1	556	Q07954
SLEDLEQLIPMEHVQ	ATCAY	301	Q86WG3
EEAMNLHPVEFAALA	FICD	341	Q9BVA6
RSILAMHAQDPQVLD	LDB2	171	O43679
EQTLMEEAPPRAQHS	PCNX3	746	Q9H6A9
DINELTNHMDEVQIP	PLXNA3	1281	P51805
TPLSEQEMNAHLAEE	PLXND1	1846	Q9Y4D7
MSAPLDAALHALQEE	IFI35	1	P80217
SSPNMVNGLEHDLLD	PDZD2	1726	O15018
FHEEITPMLDGITNN	PDE6A	791	P16499
IHSQIPALQDMHAEI	ENPP5	456	Q9UJA9
SMNRDEQDVLLVHHP	ERAL1	91	O75616
DSDMVHRPVNENDIL	HACE1	541	Q8IYU2
QDDASSPHLQVMLQI	PEG10	341	Q86TG7
ETDNDQEVIPMHLAT	LPIN1	91	Q14693
SMLPDVVDDFQLQHR	MFSD2B	391	A6NFX1
LNHMDEVPEENLERH	GBP4	261	Q96PP9
RNLHMAEAPADLEQP	LAMA2	2911	P24043
QLEDPEFQASNIMHS	F8	621	P00451
DLMHIVQADNPSISV	PNMA2	216	Q9UL42
MELEAEQLLEPHVQA	DMPK	421	Q09013
MDKDSPEVHQDLNAL	MED9	76	Q9NWA0
DMPALEQLDLHSNVL	LRRC32	171	Q14392
MAELEAVLEQHGSQP	BRCA1	1411	P38398
LEQVNALVPMLDSAH	DCTN3	101	O75935
AMSHPDNELIAEVIL	DYNC2H1	1816	Q8NCM8
HQQALDVLDMEEPIN	CDC16	86	Q13042
SDAEQMPQHTLKDQD	CHD9	616	Q3L8U1
DVSMHGLPLVQDQED	HYDIN	2426	Q4G0P3
NEMISHEQLPELDNL	BMP10	271	O95393
MQDIHKADVNEIPLN	BCLAF3	501	A2AJT9
MSQSHNDLVFLEQPE	C2CD2	646	Q9Y426
DADLHVIMNAPSIGQ	BRCA2	1161	P51587
DPEDEHLCANLMQLL	DDIT4	86	Q9NX09
VSLQELLESHPDMHA	FANCA	191	O15360
MGALNTVVENLHDPD	CYGB	86	Q8WWM9
AQLPELASAEMSLHV	ATG9B	821	Q674R7
GDSAPLNEAMAVLQH	MAN2B1	431	O00754
NMDPLLDHINSHAAE	MAN2B2	301	Q9Y2E5
LQGMAPSDQAEVDHL	ENO4	146	A6NNW6
NSLMDEDIAHKQISP	GRID1	881	Q9ULK0
VELQLLHECSPSQMD	FANCE	311	Q9HB96
EQTHALESPMNLEQA	FAM186A	1666	A6NE01
AEDILHQSPNMNAVI	HDAC9	981	Q9UKV0
MSHVVVKNDPELDQQ	DDX3Y	1	O15523
SEFHLILMDVNDNPP	CDH17	651	Q12864
LAELPALVNESDMHV	CAND2	696	O75155
VSQHMLPLQDNLEEH	CEP295	1246	Q9C0D2
QFMSLHIPEENRSVD	RYR2	1626	Q92736
QRTPLMEAAENNHLE	EHMT1	806	Q9H9B1
QVIPMEEFNLHLTGD	MTHFD1	431	P11586
NILLLQPIESDDMEH	MAP3K11	246	Q16584
MDPLNDNVATLLHQS	MYH10	596	P35580
ELHVLVMDENDNVPI	CDH16	321	O75309
TPHLVNLNEDPLMSE	KIF1A	491	Q12756
APMEDKLNQAHLEVQ	ODF2	516	Q5BJF6
LEMLSLHPDVAAAEN	HS3ST1	71	O14792
METHIPVIFLDLNAD	KIF13B	1166	Q9NQT8
FILQMEVGEPLSHEN	RTL9	1201	Q8NET4
NVLLDEMQIQHPTAS	CCT6B	61	Q92526
DDIEQLLEFMHQLPA	RAPGEF6	266	Q8TEU7
EEERATNHLDQVPSM	SPAG8	286	Q99932
HQHQSMFPTLEIDIE	ADSS1	201	Q8N142
MAQSSPQLDIQVLHD	TAB3	1	Q8N5C8
KETMNPHDIVQDAIH	TMEM184B	341	Q9Y519
VLKQDMATEHPQAEV	NKTR	1161	P30414
MVEPSQHIFDDAQLQ	RGS20	341	O76081
DMQALHESEILPFPN	MRGBP	86	Q9NV56
QELEELNMHLSDIAP	GUCY1B2	301	O75343
NAVDMPLVIILDNLH	NAV2	2216	Q8IVL1
LANNPTLDAMTEIHE	PLA2G6	656	O60733
DQHPENAAEIKLTMA	SRP72	366	O76094
LNLHLPAADQNVIMA	NCKIPSD	561	Q9NZQ3
IHNLLDQIPDMFADS	SEC24D	536	O94855
LIMATPEENSNPHDR	STRA8	21	Q7Z7C7
NAAPQERHESMPDVL	TASOR	511	Q9UK61
LTEVEMNQPQHATEL	TASOR	1156	Q9UK61
EMNLVHAPQVADAIL	CLTCL1	586	P53675
RDPNLHAIEMDSEIQ	NCAPG2	361	Q86XI2
NIHDLTQIHSDMNLP	PSME3	51	P61289
QQEASLMAELHHPNI	ROR1	521	Q01973
LDQISEESHNIMPSI	XIRP2	1221	A4UGR9
DDIEQLLEFMHQLPA	RAPGEF2	121	Q9Y4G8
NLPASLTELHINDNM	TLR8	661	Q9NR97
TPLHLAVQNGDLEMI	TRPA1	241	O75762
VLHISEENGMENPLL	UNC80	3221	Q8N2C7
LQTLHPMDAAQREEH	MKRN3	271	Q13064
HNLFEDNMALPSESV	NIBAN1	566	Q9BZQ8
IQDEMSVQLSHDPLE	SLC26A2	631	P50443
DGLMEIDSFLTQHPQ	PLCXD2	141	Q0VAA5
PTVSMAELEHLAQNI	RORA	266	P35398
LLANGMEVALQTEPH	TENM4	1771	Q6N022
MQEDFLVHEVTNLPV	TBC1D10B	591	Q4KMP7
ELVAHEPAIQNVLDM	SPTA1	1761	P02549
MTLSIPHINLSNDDD	PBK	241	Q96KB5
FEALMNQHQDPLEVT	TEK	61	Q02763
QDHRDVVMLDNLPDL	RPAP1	51	Q9BWH6
TIHEENIARLQAMAP	RPAP1	226	Q9BWH6
NIVLAVMEKNPHTAD	ZC3H12B	806	Q5HYM0
NHMESLDLITSNPEE	PLCH1	101	Q4KWH8
DTHILPSLQANDAML	TTC38	276	Q5R3I4
QALPEMEIHLQTNAE	TRAP1	136	Q12931
LDVVNMAITEHPENF	TTC7A	586	Q9ULT0
ANTMIEHDDTLPSQL	STK4	351	Q13043
IDQVNPELHDFMQSA	TBC1D20	196	Q96BZ9
DMASVHHLLSQIPQD	TBC1D20	271	Q96BZ9
PEMFADINSLQEHIR	ZNF423	486	Q2M1K9
NPHMTDAQQLAAAIL	ZC3H12C	861	Q9C0D7
VLQDRSMPHQEILAA	ZNF148	46	Q9UQR1
SMPHQEILAADEVLQ	ZNF148	51	Q9UQR1
PEANQIRASILDMAH	TRIM23	221	P36406
EIEMHADNPAAIQTV	PLEKHA5	676	Q9HAU0
QLMNVEPIHADILLE	PTPRC	626	P08575
EPLHALVTANTMENV	SF1	201	Q15637
HEVMNLEPENTLDQH	ZW10	456	O43264
EDQQMASHENPVDIL	ZNF787	16	Q6DD87
ELLDMPAAELLQDHQ	KIAA2013	321	Q8IYS2
MNLHIDEQVHRPLDT	NDC1	246	Q9BTX1